Tunisia DPM AMC Medical Device Registry: Categories, Importers & Brands
A comprehensive, database-level analysis of the Tunisia DPM AMC medical device registry. Explore category volumes, leading local importers, and country-of-origin distributions.
Executive Summary
What does the Tunisia Direction de la Pharmacie et du Médicament (DPM) database reveal about medical device AMC (Authorisation de Mise à la Consommation) approvals, top local importers, and source countries?
Tunisia's DPM AMC database lists 57,209 medical device and IVD records out of 74,836 total records (76.45%). France is the leading country of origin for these medical devices with 11,763 records (20.56%), followed by Turkey with 7,992 (13.97%) and the Netherlands with 6,696 (11.70%). The leading local importer is MEDICAL DEVICE with 5,648 registrations, followed by G.B.M with 3,202 and ORTHO & SANTE with 2,789. Orthopedic implants represent the single largest product class with 13,812 records, while active coronary stents represent 2,544. AMC medical device approvals peaked in 2025 with 29,276 records, compared to 13,344 in 2024 and 14,589 in 2026.
Introduction to the Tunisian Medical Device Market
Tunisia represents a strategic gateway to the North African and broader Middle East and North Africa (MENA) healthcare markets. With a population of over 12 million and a relatively well-developed healthcare infrastructure, the country has positioned itself as a regional hub for medical tourism, particularly for patients from neighboring Libya and Sub-Saharan Africa. The Tunisian healthcare system comprises a public sector (managed by the Ministry of Health), a social security sector, and a rapidly expanding private clinical sector.
Despite a growing local manufacturing capability for basic medical consumables and packaging, the Tunisian medtech market remains heavily dependent on imports. Approximately 90% of all medical devices, diagnostic systems, and in vitro diagnostics (IVDs) used in Tunisia are imported from foreign manufacturers. This high import reliance makes navigating the regulatory clearance and registration pathways a critical business process for international medical device developers.
The commercial importation and marketing of medical devices and IVDs in Tunisia are regulated under the authority of the Ministry of Health. The primary regulatory body responsible for evaluating product dossiers, overseeing quality compliance, and issuing import authorizations is the Direction de la Pharmacie et du Médicament (DPM) (Directorate of Pharmacy and Medicines). The DPM operates under a mandate to ensure that all health products commercialized in Tunisia meet strict standards of safety, quality, and clinical efficacy.
To provide medtech regulatory affairs managers, business development directors, and regional distributors with actionable market intelligence, MedDeviceGuide has performed a comprehensive, database-level analysis of the official Tunisian medical device registration listings. This analysis is based on the latest database extract from the DPM Authorisation de Mise à la Consommation (AMC) registry, dated June 22, 2026. By parsing, cleaning, and aggregating these records, we expose the underlying structure of the Tunisian medical device market, identifying the dominant product categories, the leading local import representatives, the primary foreign supply countries, and the chronological distribution of regulatory approvals.
For an overview of the broader North African regulatory requirements, please refer to our companion North Africa Medical Device Registration Guide.
Understanding the AMC Regulatory Framework in Tunisia
Before analyzing the registry statistics, it is essential to define the legal framework that governs medical device commercialization in Tunisia.
What is an AMC?
In Tunisia, the core regulatory certificate required for commercial marketing is the Authorisation de Mise à la Consommation (AMC) (Authorization for Placing on the Market / Consumption). An AMC is a product-specific marketing authorization issued by the DPM. Without a valid AMC, a medical device cannot be cleared through Tunisian customs, stored in local warehouses, or sold to public hospitals and private clinics.
The AMC process acts as a technical inspection gate. It applies not only to medical devices but also to pharmaceuticals, cosmetics, and food supplements. For medical devices, the DPM reviews the manufacturer's technical file, quality management system (QMS) certifications, labeling, and clinical performance data.
The Regulatory Transition to the ANMPS
Tunisia is currently undergoing a major regulatory modernization program. Under the Law on the Creation of the National Agency for Medicines and Health Products, the country is transitioning regulatory authority from the traditional DPM directorate to a newly formed, autonomous agency: the Agence Nationale des Médicaments et des Produits de Santé (ANMPS) (sometimes referred to as the ANAM).
The ANMPS is designed to consolidate regulatory supervision under a single administrative roof, streamlining the evaluation of dossiers, strengthening post-market surveillance (materiovigilance), and implementing digital submission portals. During this transition, the existing DPM guidelines, registration databases, and AMC files remain the legal basis for compliance.
The Role of the Local Representative (Mandataire)
Foreign medical device manufacturers cannot submit registration dossiers directly to the DPM. They must legally appoint a local partner—a registered Tunisian distributor or regulatory agent—to act as their Local Representative (Mandataire). The local representative submits the application via the DPM portal, manages communication with the regulators, handles sample submissions for local testing, and serves as the official license holder in the DPM AMC database.
As we will demonstrate in the importer analysis section, securing a competent and creditworthy local partner is the single most critical decision for a manufacturer entering the Tunisian market, as the representative holds substantial channel power.
Volume and Composition of the DPM AMC Registry
Our analysis of the Tunisia DPM AMC dataset extract dated June 22, 2026, reveals a total database volume of 74,836 registered product records (after skipping 3,128 duplicate rows resulting from administrative corrections and multi-packaging entries).
To isolate the medical device and in vitro diagnostic (IVD) footprint from the broader pharmaceutical and cosmetic records, we applied a keyword-based signal filter over the product description, brand, and ingredient fields. This filter isolates records containing terms such as implant, prothèse, cathéter, aiguille, seringue, pansement, stoma, dental, suture, diagnostic, and PPE.
The composition of the DPM registry is structured as follows:
- Medical Device and IVD Signal Records: 57,209 listings (76.45% of the database)
- Pharmaceuticals, Cosmetics, and Non-Device Records: 17,627 listings (23.55% of the database)
- Total Registry Records: 74,836 listings (100.00%)
This high concentration of medical device listings (76.45%) reflects the DPM's broad oversight. Unlike some regulatory agencies that focus exclusively on high-risk active implants, the DPM registers a wide range of medical consumables, diagnostic reagents, and surgical hardware under the AMC framework.
Product Category and Brand Distributions in the Tunisia DPM Registry
By analyzing the medical_device_signal_reason field—which tracks the specific keywords triggering the medical device classification—we can map the dominant product categories registered for use in Tunisia:
| Rank | Product Category Group | Signal Count | Percentage of Devices | Typical Examples in Database |
|---|---|---|---|---|
| 1 | Implant & Prosthesis | 37,907 | 66.26% | Orthopedic implants, joint prostheses, breast implants, cardiac valves |
| 2 | Orthopedic (Consumables/Hardware) | 9,448 | 16.51% | Bone plates, osteosynthesis screws, intramedullary nails, external fixators |
| 3 | Catheters & Guide Wires | 7,838 | 13.70% | Balloon dilatation catheters, central venous catheters, neurovascular guides |
| 4 | Dental Consumables & Implants | 1,545 | 2.70% | Dental implants, filling cements, orthodontic brackets, dental alloys |
| 5 | Surgical Consumables & Sutures | 1,329 | 2.32% | Absorbable sutures, surgical blades, staplers, trocars |
| 6 | Dialysis & Urology Consumables | 1,101 | 1.92% | Hemodialyzers, fistula needles, peritoneal dialysis sets |
| 7 | Personal Protective Equipment (PPE) | 759 | 1.33% | Sterile surgical gloves, protective gowns, surgical masks |
| 8 | Stoma & Urology Care | 740 | 1.29% | Ostomy bags, urinary catheters, drainage bags |
| 9 | Needles & Syringes | 706 | 1.23% | Hypodermic needles, spinal needles, insulin syringes |
| 10 | Infusion & Syringe Systems | 180 | 0.31% | IV infusion sets, extension lines, stopcocks |
| 11 | Diagnostic Equipment & Reagents | 79 | 0.14% | Rapid diagnostic test kits, clinical chemistry reagents |
| 12 | Wound Care | 38 | 0.07% | Hydrocolloid dressings, sterile gauze pads, surgical tape |
Note: Individual records may trigger multiple category signals due to compound product names.
The database is heavily dominated by Implantable Devices and Orthopedic Hardware, representing over 82% of all registered medical device entries. This concentration indicates that high-value, patient-specific implants require individual AMC listings for each size, length, and material configuration. In contrast, low-risk consumables are often grouped into broader, single-listing AMC certificates.
High-Frequency Product Names and Brands
By analyzing the top signal products in the database, we identify the specific medical device names that represent the highest volume of registry records:
- IMPLANT ORTHOPEDIQUE (Orthopedic Implants): 13,812 records. This generic designation covers a massive range of plates, screws, and pins imported from European and Turkish manufacturers.
- STENT CORONAIRE ACTIF (Active Coronary Stents): 2,544 records. High-value cardiovascular drug-eluting stents (DES) represent a major segment, indicating active clinical adoption of advanced interventional cardiology in Tunis.
- IMPLANT INTRA-OCULAIRE / INTRAOCULAIRE (Intraocular Lenses): 1,819 records (including 586 listings specifically branded under Bausch + Lomb). This highlight reflects the high volume of cataract surgeries performed in both public eye clinics and private centers.
- PROTHESE OCULAIRE (Ocular Prosthesis) & Plaque D'Osteosynthese: 1,353 records each.
- PROTHESE TOTALE DE GENOU PTG ZIMMER (Total Knee Prosthesis): 959 records. Zimmer Biomet is a major brand in the orthopedic joint replacement sector in Tunisia.
- IMPLANT DENTAIRE (Dental Implants): 776 records. Represents a diverse set of dental implant systems, reflecting Tunisia's role as a regional center for cosmetic dental tourism.
- IMPLANT MAMMAIRE (Breast Implants): 580 records. High volume driven by aesthetic surgery clinics.
- VALVE CARDIAQUE (Heart Valves): 556 records. Mechanical and bioprosthetic heart valves.
Countries of Origin Supplying Tunisia's Medtech Needs
An analysis of the provenance (country of origin) field in the DPM AMC database provides a clear picture of the export nations supplying Tunisia's medical device market.
Foreign manufacturers must prove that their devices are manufactured in compliance with international standards, and the DPM registry tracks the country where the primary manufacturing site is located:
| Rank | Country of Origin (Database spelling) | Number of Active Registrations | Percentage of Medical Devices | Primary Product Categories |
|---|---|---|---|---|
| 1 | FRANCE | 11,763 | 20.56% | Orthopedic implants, cardiovascular stents, IVD reagents, surgical gloves |
| 2 | TURQUIE (Turkey) | 7,992 | 13.97% | Orthopedic hardware, hospital consumables, sterile drapes, syringes |
| 3 | NETHERLANDS | 6,696 | 11.70% | Advanced imaging components, cardiovascular catheters, wound care |
| 4 | GERMANY | 5,779 | 10.10% | Surgical instruments, orthopedic joints, hemodialysis systems, capital hardware |
| 5 | INDIA | 3,258 | 5.70% | Generic consumables, syringes, sutures, basic diagnostic test kits |
| 6 | CHINA | 3,163 | 5.53% | Personal protective equipment, surgical consumables, low-risk diagnostics |
| 7 | ITALIE (Italy) | 3,116 | 5.45% | Urology consumables, hospital hardware, orthopedic components |
| 8 | SUISSE (Switzerland) | 2,847 | 4.98% | High-precision dental implants, trauma hardware, surgical optics |
| 9 | EMIRATS ARABES UNIS (UAE) | 2,749 | 4.80% | Packaged medical kits, syringes, regional distribution transfers |
| 10 | BELGIQUE (Belgium) | 1,534 | 2.68% | Pharmaceutical-grade consumables, IVD reagents, clinical kits |
Tunisia DPM Medical Device Supply Share (Top 5 Countries):
France: [====================] 20.56%
Turkey: [==============] 13.97%
Netherlands: [===========] 11.70%
Germany: [==========] 10.10%
India: [=====] 5.70%
The Dominance of France and Europe
France remains the leading exporter of medical devices to Tunisia, representing 20.56% of the entire medical device database (11,763 records). This dominance is driven by historical, cultural, and linguistic ties. The Tunisian medical curriculum, clinical guidelines, and regulatory procedures are heavily aligned with French systems. Most Tunisian physicians and surgeons are trained in French medical universities or maintain close professional relationships with French clinical centers, creating a strong preference for French-branded medtech.
Furthermore, French-language labeling, instructions for use (IFU), and regulatory dossiers are readily accepted by the DPM, reducing the administrative burden of translation.
When combined, European Union member states (France, Netherlands, Germany, Italy, Belgium) and Switzerland supply over 55% of all registered medical devices in Tunisia. This highlights the high value placed on CE-marked equipment by Tunisian regulators and clinicians.
The Rise of Turkey
Turkey has emerged as the second largest supplier of medical devices to Tunisia, holding 13.97% of the registry (7,992 records). This growth represents a major shift in the North African medtech landscape. Turkish manufacturers have successfully combined competitive pricing with European-standard quality certifications (CE marking under the EU MDR).
Additionally, strong trade agreements and geographic proximity allow Turkish suppliers to deliver orthopedic hardware, hospital beds, and surgical consumables to Tunis with shorter lead times than Asian competitors.
India and China: Consumables and PPE
India (5.70%) and China (5.53%) represent a combined 11.23% of the database. Their registrations are concentrated in high-volume, low-cost clinical consumables, personal protective equipment (PPE), syringes, and basic diagnostic test kits. In high-value, active implantable categories (like pacemakers, neurostimulators, and active stents), India and China hold a very small registry footprint, where US and Western European brands continue to dominate.
The Leading Local Importers and Channel Concentration
In Tunisia, securing the right local partner is the single most critical commercial decision. Because the DPM registry requires all AMC registrations to be tied to a local corporate entity, the local representative holds substantial channel power.
Our database analysis reveals that the Tunisian medtech import channel is highly concentrated. A small group of specialized distributors in Tunis controls a massive share of the authorized product listings:
| Rank | Local Importer Name | Number of AMC Listings | Percentage of Device Registry | Primary Portfolio & Specialty |
|---|---|---|---|---|
| 1 | MEDICAL DEVICE | 5,648 | 9.87% | Orthopedic implants, bone plates, trauma hardware |
| 2 | G.B.M | 3,202 | 5.60% | Cardiovascular devices, stents, active implants, diagnostic imaging |
| 3 | ORTHO & SANTE | 2,789 | 4.87% | Orthopedic joints, knee/hip prostheses, rehabilitation hardware |
| 4 | GENERAL MEDICAL DISTRIBUTION | 2,739 | 4.79% | General surgery consumables, sutures, clinical disposables |
| 5 | MBE MEDICAL | 2,272 | 3.97% | Advanced diagnostics, clinical chemistry systems, IVD lines |
| 6 | TOUCOMEX | 2,036 | 3.56% | Specialized surgical implants, cardiovascular catheters |
| 7 | DI.MED.TEC | 2,008 | 3.51% | Urology, stoma care, hospital consumables |
| 8 | PROCHIDIA | 1,852 | 3.24% | Laboratory reagents, diagnostic kits, clinical equipment |
| 9 | K.T.BIO | 1,815 | 3.17% | Biotechnology consumables, IVD reagents |
| 10 | MEDICOM | 1,543 | 2.70% | Critical care consumables, anesthesia systems |
| 11 | GENERAL BUSINESS TRADING | 1,494 | 2.61% | General clinical consumables, PPE, hospital supplies |
| 12 | SOGEMM | 1,433 | 2.50% | Dental implants, dental clinic equipment, orthodontics |
| 13 | CADUCEE INTER TRADE | 1,344 | 2.35% | Cardiovascular accessories, general surgery lines |
| 14 | IMPLANTCAST TUNISIE | 1,154 | 2.02% | Specialized joint reconstruction, tumor prostheses |
| 15 | PRODESSE ORTHO | 1,185 | 2.07% | Trauma hardware, spinal implants |
Tunisia Top Importer AMC Registry Holdings:
MEDICAL DEVICE: [=========================] 5,648
G.B.M: [==============] 3,202
ORTHO & SANTE: [============] 2,789
GEN MED DIST: [===========] 2,739
MBE MEDICAL: [==========] 2,272
Importer Concentration Metrics
The top five local importers (MEDICAL DEVICE, G.B.M, ORTHO & SANTE, GENERAL MEDICAL DISTRIBUTION, and MBE MEDICAL) control a combined 16,650 AMC listings, representing 29.07% of the entire medical device registry.
This concentration highlights the following market realities:
- Consolidated Channel Power: The top distributors hold significant leverage. They possess established regulatory departments that maintain direct communication channels with DPM evaluators, allowing them to secure AMC approvals faster than smaller, less experienced firms.
- Specialization Hubs:
- MEDICAL DEVICE (5,648 listings) and ORTHO & SANTE (2,789 listings) are highly specialized in orthopedics, trauma, and joint reconstruction.
- G.B.M (3,202 listings) dominates the high-value cardiovascular and diagnostic imaging sectors, representing major multinational brands.
- MBE MEDICAL (2,272 listings) and PROCHIDIA (1,852 listings) focus on laboratory diagnostics and in vitro diagnostic (IVD) systems.
- The Representative Lock-In Risk: Because the AMC registration is linked to the local importer's name, changing distributors in Tunisia can be administratively difficult. If a relationship degrades, the foreign manufacturer must obtain a formal "Transfer Consent Letter" from the existing representative to assign the AMC to a new partner. If the current distributor refuses, the manufacturer may be forced to wait for the AMC to expire or submit a brand-new registration dossier, causing severe market disruptions.
Chronological Trends in AMC Approvals
Analyzing the DPM AMC approval dates reveals a distinct expansion of the Tunisian regulatory registry over the last three years:
- 2024 Approved Medical Device AMCs: 13,344 records
- 2025 Approved Medical Device AMCs: 29,276 records
- 2026 Approved Medical Device AMCs: 14,589 records (reflecting listings approved or updated through mid-June 2026)
This massive spike in approvals in 2025 (29,276 records, representing a 119% increase YoY) is attributed to two factors:
- DPM Backlog Clearing: Following administrative disruptions and transition delays in 2022–2023, the DPM initiated a focused effort to clear backlog dossiers, resulting in a wave of bulk approvals for historical submissions.
- Tighter Customs Enforcement: The Tunisian Ministry of Finance and Customs Authority implemented stricter enforcement of AMC clearances at ports of entry. This forced local importers to formalize individual AMC registrations for every product variation and accessory that had previously been imported under generic, group-level custom declarations.
The June 2026 eCTD Transition and Modernization Roadmap
To align with international best practices and prepare for the full operational handover of the Agence Nationale des Médicaments et des Produits de Santé (ANMPS), Tunisia is implementing a transition to electronic submissions.
What is the eCTD Mandate?
Historically, DPM submissions required physical binders of dossiers, paper applications, and manual signatures. The updated regulatory roadmap mandates that all new medical device registrations, variations, and renewals must be submitted in the electronic Common Technical Document (eCTD) format.
The transition timeline is structured as follows:
- Phase 1 (Active): Voluntary eCTD pilot program for high-risk implantable devices (Class III/IV equivalent) and active cardiovascular systems.
- Phase 2 (June 2026 Milestone): Mandatory eCTD submission for all new medical device and IVD registration applications.
- Phase 3 (Projected follow-on): Extension of mandatory eCTD to post-authorization variations, QMS updates, and 5-year AMC renewals. The operative dates for this later phase are still being phased in — confirm the current ANMPS roadmap before planning around a specific variation or renewal deadline.
Operational Impact on Foreign Manufacturers
The shift to eCTD requires manufacturers to carefully prepare their technical dossiers. The traditional practice of compiling unstructured PDF files will no longer be accepted. Dossiers must be structured according to the standard eCTD 5-module hierarchy, including:
- Module 1: Administrative information and regional requirements (local representative details, power of attorney, legalized Certificate of Free Sale).
- Module 2: Quality, non-clinical, and clinical summaries.
- Module 3: Chemical, physical, and biological documentation (biocompatibility reports, sterilization validation, software lifecycle documentation under IEC 62304 for active software).
- Module 4: Non-clinical study reports.
- Module 5: Clinical study reports and clinical evaluation dossiers.
All technical documents must be submitted in French or English, while administrative documents and labeling must satisfy specific language mandates.
Practical Guidance: Step-by-Step AMC Submission Pathway in Tunisia
To secure an AMC in Tunisia, foreign manufacturers and their local representatives must execute a structured, sequential regulatory pathway:
[Phase 1: Partner Selection]
Appoint a Local Representative in Tunis
Execute a Notarized Power of Attorney (PoA)
↓
[Phase 2: Dossier Preparation]
Compile Technical File (eCTD format)
Secure legalized Certificate of Free Sale (CFS)
Ensure Bilingual Labeling (French/Arabic)
↓
[Phase 3: Administrative Submission]
Local Partner submits dossier via DPM/ANMPS Portal
Pay Official Evaluation Fee
↓
[Phase 4: Technical & Laboratory Control]
Submit Product Samples to LNCM (Laboratoire National)
Pass physical, chemical, and sterility analysis
↓
[Phase 5: Committee Review & Issuance]
Presentation to the DPM Medical Device Commission
Issue AMC Certificate (Valid for 5 Years)
Step 1: Appoint the Local Representative (Mandataire)
The manufacturer must execute a formal Power of Attorney (PoA) appointing a registered Tunisian medical device distributor as their regulatory agent. The PoA must be notarized by a notary public in the country of origin and legalized by the Tunisian Embassy.
Step 2: Dossier Compilation
The manufacturer compiles the technical file according to the new eCTD structure. Key documents include:
- Certificate of Free Sale (CFS): Proving the device is cleared for marketing in its country of origin (e.g., FDA Certificate to Foreign Government, or EU MDR Certificate of Free Sale). The CFS must be legalized by the Tunisian Embassy.
- Declaration of Conformity (DoC): Confirming compliance with EU MDR or reference regulations.
- ISO 13485 Certificate: Covering the manufacturing facility.
- Labeling and Instructions for Use (IFU): Must be in French. For products intended for direct patient use or self-testing, key warnings must also be provided in Arabic.
Step 3: Portal Submission and Fee Payment
The local representative uploads the eCTD dossier to the DPM portal and pays the administrative evaluation fee. For imported medical devices, the evaluation fee typically ranges from 500 to 1,500 Tunisian Dinars (TND) per application, depending on the risk class and complexity.
Step 4: Laboratory Control (LNCM)
A critical requirement in Tunisia is the physical inspection and laboratory testing of product samples. The manufacturer must ship sample units of the medical device (along with calibrators and control reagents for IVDs) to the Laboratoire National de Contrôle des Médicaments (LNCM) (National Laboratory for the Control of Medicines) in Tunis. The LNCM performs physical, chemical, and microbiological sterility tests to verify that the device matches its technical file specifications.
Step 5: Commission Review and AMC Approval
Upon receiving a passing report from the LNCM and a favorable dossier evaluation from DPM technical reviewers, the application is presented to the DPM Medical Device Commission. Upon approval, the DPM issues the official AMC certificate, which includes the product's AMC registration code and the authorized local representative's name.
Step 6: Importation and Customs Clearance
Once the AMC is issued, the local representative can apply for technical control approval at the port of entry for each incoming shipment. Customs officials cross-reference the shipment invoice against the DPM AMC database. If the product name, model number, or manufacturing site does not match the AMC listing, the shipment is frozen.
Regional Comparison: North Africa Registration Landscape
The regulatory pathways in Tunisia exhibit distinct operational differences compared to neighboring Morocco and Algeria. Medtech exporters must understand these variations to structure their regional commercial strategies:
| Parameter | Tunisia (DPM / ANMPS) | Morocco (DMP / AMMPS) | Algeria (ANPP) |
|---|---|---|---|
| National Regulator | Direction de la Pharmacie et du Médicament | Direction du Médicament et de la Pharmacie | Agence Nationale des Produits Pharmaceutiques |
| Marketing Authorization | AMC (Authorisation de Mise à la Consommation) | Certificat d'Enregistrement (Registration Certificate) | Décision d'Enregistrement (Registration Decision) |
| Validity Period | 5 Years | 5 Years | 5 Years |
| Dossier Format | eCTD Mandate (Effective June 2026) | GHTF Technical File / Common Dossier | eCTD / National Dossier Format |
| Mandatory Lab Testing | Yes (LNCM sample testing required) | No (Only under specific safety concerns) | No (Registration based on dossier review) |
| Local Rep Requirement | Mandatory Local Mandataire (Distributor) | Mandatory Moroccan Representative (Establishment License) | Mandatory Algerian Partner (Joint-Venture or Licensed Agent) |
| Average Timeline | 4 to 9 Months | 6 to 12 Months | 8 to 18 Months |
| Key Operational Hurdles | Mandatory sample shipment and LNCM lab testing delays | Strict site audit requirements for non-reference country sites | Heavy focus on local manufacturing partnerships and import quotas |
Frequently Asked Questions (FAQs)
What does AMC stand for in Tunisia medical device regulations?
AMC stands for Authorisation de Mise à la Consommation (Authorization for Placing on the Market / Consumption). It is the mandatory product registration certificate issued by the Direction de la Pharmacie et du Médicament (DPM) required to import, market, and clear medical devices through customs in Tunisia.
Which country is the largest exporter of medical devices to Tunisia in the DPM registry?
France is the largest exporter, representing 20.56% of all medical device listings (11,763 records) in the DPM registry. This dominance is driven by historical clinical alignment, linguistic ties, and the ready acceptance of French-language dossiers and labeling.
What is the validity period of a Tunisian DPM AMC certificate?
A Tunisian AMC is valid for exactly five years. The local representative must initiate the renewal process at least 6 months before the expiration date to prevent shipping delays and customs blocks.
Can a foreign manufacturer hold the AMC registration directly?
No. Only a registered Tunisian entity (such as a licensed medical distributor or local agent) appointed as the Local Representative (Mandataire) can submit the application and hold the AMC license in the DPM database.
Are product samples required for registration in Tunisia?
Yes. Unlike many countries that perform document-only reviews, Tunisia requires the submission of physical product samples to the Laboratoire National de Contrôle des Médicaments (LNCM) for laboratory testing and verification before an AMC can be issued.
Sources and Database Metadata
- Primary Dataset: Direction de la Pharmacie et du Médicament (DPM) AMC Product Registry:
https://dpm.tn/dpm_pharm/aspamc/listproduit.php - Importer Reference Data: DPM Authorized Importer Directory:
https://dpm.tn/dpm_pharm/aspamc/listimport.php - National Laboratory Reference: Laboratoire National de Contrôle des Médicaments (LNCM) Technical Guidelines:
https://dpm.tn/controle-technique/amc-dispositifs-medicaux - Analysis Extract Date: June 22, 2026.
- Total Analyzed Sample: 74,836 total records; 57,209 medical device and IVD records.
Disclaimer: The statistical data, rankings, and regulatory insights presented in this analysis are derived from the Tunisia DPM public AMC registry database extract dated June 22, 2026. They are intended for educational and strategic planning purposes only. Foreign manufacturers must verify current registration fees, dossier formats (eCTD), sample requirements, and import protocols directly with the DPM/ANMPS or their appointed local representatives in Tunis before making commercial decisions.